Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy
AIM: To compare the efficacy and safety of 577nm subthreshold micropulse laser(SML)and photodynamic therapy(PDT)in patients with chronic central serous chorioretinopathy(cCSC).<p>METHODS: Thirty patients(30 eyes)with cCSC were treated in our hospital from February 2015 to April 2018. And 15 pa...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2019-06-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2019/6/201906039.pdf |
id |
doaj-00b5b8315ca24429b8b2adc0c4a31c0c |
---|---|
record_format |
Article |
spelling |
doaj-00b5b8315ca24429b8b2adc0c4a31c0c2020-11-24T20:47:10ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232019-06-011961063106710.3980/j.issn.1672-5123.2019.6.39Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathyWei Shi0Gui-Sen Zhang1Yan-Nian Hui2Lei Liu3Xiao-Guang Zhang4Yan-Jie Kang5Yang Liu6Inner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaDepartment of Ophthalmology, Air Force Medical University, Xijing Hospital, Xi'an 710015, ChinaThe First Hospital of China Medical University, Shenyang 110001,ChinaCo-first authors: Wei Shi and Gui-Sen ZhangInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaAIM: To compare the efficacy and safety of 577nm subthreshold micropulse laser(SML)and photodynamic therapy(PDT)in patients with chronic central serous chorioretinopathy(cCSC).<p>METHODS: Thirty patients(30 eyes)with cCSC were treated in our hospital from February 2015 to April 2018. And 15 patients(15 eyes)were treated with SML(577 nm)while the others were treated by PDT. The BCVA and CMT as well as complications were observed at 1, 3, 6mo after treatment.<p>RESULTS: At 1mo after treatment, BCVA was increased to 0.37±0.13 in SML group and 0.20±0.11 in PDT group(<i>t</i>=-3.93, <i>P</i><0.001); CMT was decreased to 382.80±76.54μm in SML group and 247.60±28.46μm in PDT group(<i>t</i>=-6.41, <i>P</i><0.001). Although improvements of BCVA and CMT were both achieved in two groups, improvements in PDT group were better than those in SML group. At 3mo and 6mo after treatment, both BCVA and CMT were no significant difference between the two groups(<i>P</i>>0.05). During the follow-up period, there were no obvious complications or recurrence observed.<p>CONCLUSION: Both SML(577nm)and PDT were effective and safe in the treatment of cCSC, but the theraputic effects of PDT was slightly quicker than SML. Further, with the prolongation of recovery time, the curative effects of these treatments were similar. Additionally, SML(577nm)costs was much cheaper than PDT and had no risk of injury or allergy for patients, and patients with cCSC could also be treated repeatedly using it.http://ies.ijo.cn/cn_publish/2019/6/201906039.pdfchronic central serous chorioretinopathy577nm subthreshold micropulse laserphotodynamic therapycentral macular thicknessOCT |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wei Shi Gui-Sen Zhang Yan-Nian Hui Lei Liu Xiao-Guang Zhang Yan-Jie Kang Yang Liu |
spellingShingle |
Wei Shi Gui-Sen Zhang Yan-Nian Hui Lei Liu Xiao-Guang Zhang Yan-Jie Kang Yang Liu Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy Guoji Yanke Zazhi chronic central serous chorioretinopathy 577nm subthreshold micropulse laser photodynamic therapy central macular thickness OCT |
author_facet |
Wei Shi Gui-Sen Zhang Yan-Nian Hui Lei Liu Xiao-Guang Zhang Yan-Jie Kang Yang Liu |
author_sort |
Wei Shi |
title |
Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy |
title_short |
Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy |
title_full |
Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy |
title_fullStr |
Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy |
title_full_unstemmed |
Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy |
title_sort |
comparison of subthreshold micropulse laser treatment and pdt in patients with chronic central serous chorioretinopathy |
publisher |
Press of International Journal of Ophthalmology (IJO PRESS) |
series |
Guoji Yanke Zazhi |
issn |
1672-5123 1672-5123 |
publishDate |
2019-06-01 |
description |
AIM: To compare the efficacy and safety of 577nm subthreshold micropulse laser(SML)and photodynamic therapy(PDT)in patients with chronic central serous chorioretinopathy(cCSC).<p>METHODS: Thirty patients(30 eyes)with cCSC were treated in our hospital from February 2015 to April 2018. And 15 patients(15 eyes)were treated with SML(577 nm)while the others were treated by PDT. The BCVA and CMT as well as complications were observed at 1, 3, 6mo after treatment.<p>RESULTS: At 1mo after treatment, BCVA was increased to 0.37±0.13 in SML group and 0.20±0.11 in PDT group(<i>t</i>=-3.93, <i>P</i><0.001); CMT was decreased to 382.80±76.54μm in SML group and 247.60±28.46μm in PDT group(<i>t</i>=-6.41, <i>P</i><0.001). Although improvements of BCVA and CMT were both achieved in two groups, improvements in PDT group were better than those in SML group. At 3mo and 6mo after treatment, both BCVA and CMT were no significant difference between the two groups(<i>P</i>>0.05). During the follow-up period, there were no obvious complications or recurrence observed.<p>CONCLUSION: Both SML(577nm)and PDT were effective and safe in the treatment of cCSC, but the theraputic effects of PDT was slightly quicker than SML. Further, with the prolongation of recovery time, the curative effects of these treatments were similar. Additionally, SML(577nm)costs was much cheaper than PDT and had no risk of injury or allergy for patients, and patients with cCSC could also be treated repeatedly using it. |
topic |
chronic central serous chorioretinopathy 577nm subthreshold micropulse laser photodynamic therapy central macular thickness OCT |
url |
http://ies.ijo.cn/cn_publish/2019/6/201906039.pdf |
work_keys_str_mv |
AT weishi comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy AT guisenzhang comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy AT yannianhui comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy AT leiliu comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy AT xiaoguangzhang comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy AT yanjiekang comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy AT yangliu comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy |
_version_ |
1716810914423898112 |